Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
S. P. Tandon, A. Khutarkar, S. Ansari, M. Khale, S. K. Rajan, J. Deodhar, J. P. Agarwal, P. Chaturvedi, P. Pai, D. Chaukar, R. Havaldar, S. Laskar, P. Yadav, A. K. D‘Cruz (Mumbai, India). Are upper airways resistance syndrome and obstructive sleep apnea a side-effect of oral cancer therapy?. Eur Respir J 2011; 38: Suppl. 55, 3468

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of intranasal corticosteroid therapy on lower respiratory tract responsiveness in children with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 419s Year: 2006 The use of systemic corticosteroids in children with obstructive sleep apnea syndrome Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill Year: 2019 Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Influence of electrostimulation of pharyngeal and laryngeal muscles in complex with traditional treatment of COPD on functional signs of obstructive sleep apnea syndrome in patients with combined pathology – obstructive sleep apnea syndrome + COPD Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Postural effects on nasal resistance in obstructive sleep apnoea (OSA) and efficacy of a novel oral appliance Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP) Year: 2018 Low prevalence of obstructive sleep apnoea in paediatric severe therapy resistant asthma Source: International Congress 2019 – Asthma education: lifestyle and adolescence Year: 2019 Respiratory failure in obstructive sleep apnea syndrome (OSAS)- is CPAP therapy alone adequate? Source: Eur Respir J 2005; 26: Suppl. 49, 111s Year: 2005 Why should we care about upper airway inflammation in obstructive sleep apnoea? Source: Eur Respir J 2016; 48: 982-983 Year: 2016 CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Source: Eur Respir J 2010; 35: 132-137 Year: 2010 Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Nasal continuous airway pressure therapy and respiratory infections in patients with obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004 Particularities of clinical-functional characteristics of combination pathology - obstructive sleep apnea-hypopnea syndrome and bronchial asthma during the treatment with prolonged beta2-agonists Source: Eur Respir J 2003; 22: Suppl. 45, 468s Year: 2003 A study of insulin resistance in moderate to severe obstructive sleep apnea in non diabetics and its response to nasal CPAP treatment Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 Patients with obstructive sleep apnoea free of nasal obstruction have increased oral breathing Source: Annual Congress 2007 - Pathogenesis of obstructive sleep apnoea Year: 2007 Airway inflammation in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002 Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea Year: 2006 Effect of treating severe nasal obstruction on the severity of obstructive sleep apnoea Source: Eur Respir J 2005; 25: 521-527 Year: 2005 Pathophysiology of the upper airway in obstructive sleep apnoea Source: Annual Congress 2009 - PG5 Core Curriculum Postgraduate Course: Obstructive sleep apnoea – current pathophysiological, clinical and therapeutic concepts Year: 2009